Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
CN |
|
Native Mineral Resources Holdings Ltd
ASX:NMR
|
AU |
|
S
|
Solaer Renewable Energies Ltd
TASE:SOLR
|
IL |
Wall Street
Price Targets
Price Targets Summary
Chongqing Zhifei Biological Products Co Ltd
According to Wall Street analysts, the average 1-year price target for
Chongqing Zhifei Biological Products Co Ltd
is 24.1 CNY
with a low forecast of 16.16 CNY and a high forecast of 33.6 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Chongqing Zhifei Biological Products Co Ltd's stock price target?
Price Target
24.1
CNY
According to Wall Street analysts, the average 1-year price target for
Chongqing Zhifei Biological Products Co Ltd
is 24.1 CNY
with a low forecast of 16.16 CNY and a high forecast of 33.6 CNY.
What is Chongqing Zhifei Biological Products Co Ltd's Revenue forecast?
Projected CAGR
-23%
For the last 13 years the
compound annual growth rate for
Chongqing Zhifei Biological Products Co Ltd's revenue is
33%.
The projected
CAGR
for the next 3 years is
-23%.
What is Chongqing Zhifei Biological Products Co Ltd's Operating Income forecast?
Projected CAGR
-37%
For the last 13 years the
compound annual growth rate for
Chongqing Zhifei Biological Products Co Ltd's operating income is
23%.
The projected
CAGR
for the next 3 years is
-37%.
What is Chongqing Zhifei Biological Products Co Ltd's Net Income forecast?
Projected CAGR
-21%
For the last 13 years the
compound annual growth rate for
Chongqing Zhifei Biological Products Co Ltd's net income is
20%.
The projected
CAGR
for the next 3 years is
-21%.
